Polydeoxyribonucleotide (defibrotide) protects against post-ischemic behavioral, electroencephalographic and neuronal damage in the gerbil

European Journal of Pharmacology

Volumn 328, Issue 2-3, 1997, Pages 143-152

  Sala, Mariaelvina ^a   Leone, Maria Primula ^a   Lampugnani, Paola ^a   Matturri, Luigi ^b   Gori, Enzo ^a  

^a Institute of Pharmacology   (Italy)

^b IRCCS   (Italy)

Author keywords

Cerebral ischemia; Defibrotide; EEG (electroencephalographic) spectral power; Memory; Neuronal damage

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; DEFIBROTIDE; POLYDEOXYRIBONUCLEOTIDE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN ISCHEMIA; BRAIN PROTECTION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ELECTROENCEPHALOGRAM; GERBIL; HIPPOCAMPUS; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; MEMORY; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; POWER SPECTRUM; PRIORITY JOURNAL; PROTECTION; RECTUM TEMPERATURE; THERMISTOR;

EID: 0030913418     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)83040-3     Document Type: Article

References (47)

1. Ader R., Weijnen J.A.W.M., Moleman P. Retention of a passive avoidance response as a function of the intensity and duration of electric shock. Psychonom. Sci. 26:1972;125-128.
2. Araki H., Nojiri M., Kawashima K., Kimura M., Aihara H. Behavioral, electroencephalographic and histopathological studies on Mongolian gerbils with occluded common carotid arteries. Physiol. Behav. 38:1986;89-94.
3. Barone D., Salvetti L., Bianchi G., Calvani A.B., Mantovani M., Prino G. On the molecular site of action of defibrotide. Pharmacol. Res. 25:1992;123-124.
4. Barzaghi F., Dragonetti M., Formento M.L., Boissier J.R. Effects of the new eburnamenine derivative RU 24722 on EEG recovery and cerebral energy metabolism after complete ischemia. Arzneim.-Forsch. 35:1985;472-477.
5. Barzaghi F., Dragonetti M., Formento M.L., Gueniau C., Nencioni A., Mantegazza P. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline. Arzneim.-Forsch. 36:1986;1142-1148.
6. Bianchi, G., Alberico, P., Tettamanti, R., Mantovani, M., Prino, G., Rossoni, G., Berti, F., 1990. Defibrotide, a prostacyclin releasing agent, protects the rabbit kidney from acute failure. In: Samuelsson, B. et al. (Eds.) Advances in Prostaglandin, Thromboxane and Leukotriene Research. Raven Press, New York, NY, Vol. 21, pp. 711-714.
7. Bianchi G., Mantovani M., Prino G., Salvetti L., Barone D. Possible agonistic interaction of defibrotide, a DNA derivative, with adenosine receptors 'in vitro'. Nucleosides Nucleotides. 10:1991;1149-1150.
8. Brierly, J.B., Graham, D.I., 1984. Hypoxia and vascular disorders of the central nervous system. In: Adams J.H., Corsellis, J.A.N., Duchen, L.W. (Eds.) Greenfield's Neuropathology. John Wiley&Sons, New York, NY, pp. 125-207.
9. Chandler M.J., DeLeo J., Carney J.M. An unanesthetized-gerbil model of cerebral ischemia-induced behavioral changes. J. Pharmacol. Methods. 14:1985;137-146.
10. Deszi L., Greenberg J.H., Hamar J., Sladky J., Karp A., Reivich M. Acute improvement in histological outcome by MK-801 following focal cerebral ischemia and reperfusion in the cat independent of blood flow changes. J. Cereb. Blood Flow Metab. 12:1992;390-399.
11. Deszi L., Greenberg J.H., Sladky J., Araki N., Hamar J., Reivich M. Prolonged effects of MK-801 in the cat during focal cerebral ischemia and recovery: survival EEG activity and histopathology. J. Neurol. Sci. 121:1994;110-120.
12. 2+ dependent neutrophil activation: implications for its pharmacological activity in vascular disorders. Angiology. 1991;971-978.
13. European Patent. No. 263155 (1991).
14. Fredholm B.B., Dunwiddie T.V. How does adenosine inhibit transmitter release? Trends Pharmacol. Sci. 9:1988;130-134.
15. Hagberg, H., Andersson, P., Ostwald, C., 1986. Ischemia-evoked release of neuroactive compounds and acute effect of N-methyl-D-aspartate receptor blockade. In: Kriegelstein, J. (Ed.), Pharmacology of Cerebral Ischemia. Elsevier, Amsterdam, pp. 298-303.
16. Hoffman C.A., Boast C.A. Neuroprotection by MK-801 in temperature maintained gerbils. Brain Res. Bull. 38:1995;405-409.
17. Hunter A.J., Green A.R., Cross A.J. Animal models of acute ischemic stroke: can they predict clinically successful neuroprotective drugs? Trends Pharmacol. Sci. 16:1995;123-128.
18. Jasper R.M.A., Block F., Heim C., Sontag K.H. Spatial learning is affected by transient occlusion of common carotid arteries (2VO): comparison of behavioural and histopathological changes after '2VO' and 'four-vessel-occlusion'. Neurosci. Lett. 117:1990;149-153.
19. Katoh A., Ishibashi C., Shiomi T., Takahara Y., Masami E. Ischemia-induced irreversible deficit of memory function in gerbils. Brain Res. 577:1992;57-63.
20. Kiyota Y., Hamajo K., Miyamoto M., Nagaoka M. Effect of idebenone (CV-2619) on memory impairment observed in passive avoidance task in rats with cerebral embolization. Jpn. J. Pharmacol. 37:1985;300-302.
21. LaPoncin-Lafitte M., Grosdemogue C., RoyBillon C., Potrat P., Lespinasse P., Rapin J.R. Short-term memory and cerebral ischemia: pharmacological application. Eur. Neurol. 20:1981;265-269.
22. Levine S., Sohn D. Cerebral ischemia in infant and adult gerbil. Arch. Pathol. Lab. Med. 87:1969;315-317.
23. Loskota, W.J., Lomax, P.L., Verity, M.A., 1974. A Stereotaxic Atlas of the Mongolian Gerbil (Meriones Unguiculatus). Ann Arbor Science Publishers, Ann Arbor, MI, pp. 1-157.
24. Marni A., Ferrero M.E., Rovati M., Salari P.C., Gaja G. Protection of kidney from postischemic reperfusion injury in rats treated with defibrotide. Transplant. Proc. 22:1990;2226-2229.
25. ++ influx in the pathogenesis of delayed neuronal death after brief forebrain ischemia in gerbils. Brain Res. 613:1993;181-192.
26. Niada R., Porta R., Pescador R., Mantovani M., Prino G. Cardioprotective effects of defibrotide in acute myocardial ischemia in the cat. Thromb. Res. 38:1985;71.
27. Niada R., Porta R., Pescador R., Mantovani M., Prino G. Protective activity of defibrotide against lethal acute myocardial ischemia in the cat. Thromb. Res. 42:1986;363-374.
28. Niada R., Porta R., Pescador R., Mantovani M., Prino G., Berti F. Cardioprotective effects of defibrotide in acute lethal and non-lethal myocardial ischemia in the cat. Haemostasis. 16:1986;18-25.
29. Nunn J., Hodges H. Cognitive deficits induced by global cerebral ischemia: relationship to brain damage and reversal by transplants. Behav. Brain Res. 65:1994;1-31.
30. 2A receptors. Trends Pharmacol. Sci. 17:1996;364-372.
31. Palmer K.J., Goa L. Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders. Drugs. 45:1993;259-294.
32. Pardridge W.M. Neuropeptides and the blood brain barrier. Annu. Rev. Physiol. 45:1983;73-82.
33. Paschen W., Schmidt-Kastner R., Hallimayer J., Djuricic B. Polyamines in cerebral ischemia. Neurochem. Pathol. 9:1988;1-20.
34. Peruche B., Klaassens H., Krieglstein J. Quantitative analysis of the electrocorticogram after forebrain ischemia in the rat. Pharmacology. 50:1995;229-237.
35. Phillis J.W. Adenosine in the control of the cerebral circulation. Cerebrovasc. Brain Metab. Rev. 1:1989;26-54.
36. Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sci. 13:1992;439-445.
37. Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Adenosine and brain ischemia. Cerebrovasc. Brain Metab. Rev. 4:1992;346-369.
38. Sala M., Leone M.P., Lampugnani P., Braida D., Gori E. Different kinetics of tolerance to behavioral and electroencephalographic effects of chlordiazepoxide in the rat. Eur. J. Pharmacol. 273:1995;35-45.
39. Schmid-Kaster R., Freund T.F. Selective vulnerability of hippocampus in brain ischemia. Neuroscience. 40:1991;599-636.
40. Simon R.P., Swan J.H., Griffiths T., Meldrum B.S. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 226:1984;850-852.
41. Stevens M.K., Yaksh T.L. Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia. J. Cereb. Blood Flow Metab. 10:1990;77-88.
42. Suzuki R., Yamaguchi T., Li C.L., Klatzo I. The effects of 5-minute ischemia in Mongolian gerbils. II. Changes of spontaneous neuronal activity in cerebral cortex and CA1 sector of hippocampus Acta Neuropathol. 60:1983;217-222.
43. Szikszay M., Benedek G., Oba F. Capsaicin pretreatment interferes with thermoregulatory effect of morphine. Pharmacol. Biochem. Behav. 18:1983;373-378.
44. Thiemermann C., Thomas G.R., Vane J.R. Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischemia and reperfusion. Br. J. Pharmacol. 97:1989;401-408.
45. Volpe B.T., Hirst W. The characterization of an amnesic syndrome following hypoxic injury. Arch. Neurol. 40:1983;436-440.
46. Wang D., Corbett D. Cerebral ischemia, locomotor activity and spatial mapping. Brain Res. 533:1990;78-82.
47. Zirh et al., 1992. Abstract. Thromb. Res. 65 (Suppl. 1), S45.